newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update

Reports Improved Outcomes in Phase 1b COVID-19 Study and Positive Trend in Peripheral Oxygenation in Phase 1b TCOM Study Expects to Announce Initial Indication and Regulatory Pathway in Fourth Quarter of 2021 and Initiate Clinical Outcome Study in Fir